8-substituted 2-amino-[1,2,4] triazolo [1, 5-A] pyrazines as Syk tryrosine kinase inhibitors and GCN2 serin kinase inhibitors
申请人:Merck Patent GmbH
公开号:US09120804B2
公开(公告)日:2015-09-01
Compounds of the formula I
in which R1, R2 and R4 have the meanings indicated in Claim 1, are inhibitors of Syk, and can be employed, inter alia, for the treatment of cancer, rheumatoid arthritis and/or systemic lupus.
8-SUBSTITUTED 2-AMINO-[1,2,4]TRIAZOLO[1,5-A]PYRAZINES AS SYK TRYROSINE KINASE INHIBITORS AND GCN2 SERIN KINASE INHIBITORS
申请人:Merck Patent GmbH
公开号:EP2817310B1
公开(公告)日:2018-03-21
8 - SUBSTITUTED 2 -AMINO - [1,2,4]TRIAZOLO [1, 5 -A]PYRAZINES AS SYK TRYROSINE KINASE INHIBITORS AND GCN2 SERIN KINASE INHIBITORS
申请人:Merck Patent GmbH
公开号:EP2817310A1
公开(公告)日:2014-12-31
US9120804B2
申请人:——
公开号:US9120804B2
公开(公告)日:2015-09-01
[EN] 8 - SUBSTITUTED 2 -AMINO - [1,2,4] TRIAZOLO [1, 5 -A] PYRAZINES AS SYK TRYROSINE KINASE INHIBITORS AND GCN2 SERIN KINASE INHIBITORS<br/>[FR] 2-AMINO-[1,2,4]TRIAZOLO[1,5-A]PYRAZINES SUBSTITUÉES EN 8ÈME POSITION EN TANT QU'INHIBITEURS DE LA TYROSINE KINASE SYK ET EN TANT QU'INHIBITEURS DE LA SÉRINE KINASE GCN2
申请人:MERCK PATENT GMBH
公开号:WO2013124026A1
公开(公告)日:2013-08-29
Compounds of the formula I in which R1, R2 and R4 have the meanings indicated in Claim 1, are inhibitors of Syk, and can be employed, inter alia, for the treatment of cancer, rheumatoid arthritis and / or systemic lupus